Narcolepsy Treatment with Dextroamphetamine

Introduction to Narcolepsy Treatment

The American Academy of Sleep Medicine conditionally recommends dextroamphetamine as a second-line treatment for narcolepsy in adults, reserved for cases where first-line agents are ineffective or contraindicated 1, 2

The American Academy of Sleep Medicine strongly recommends modafinil as a first-line treatment for narcolepsy, with moderate-quality evidence showing improvements in excessive daytime sleepiness, disease severity, and quality of life 3
The American Academy of Sleep Medicine strongly recommends solriamfetol as a first-line treatment for narcolepsy, with high-quality evidence demonstrating clinically significant improvements in excessive daytime sleepiness and disease severity 4, 5
The American Academy of Sleep Medicine strongly recommends sodium oxybate as a first-line treatment for narcolepsy, particularly effective for both excessive daytime sleepiness and cataplexy with moderate-quality evidence 4, 5
The American Academy of Sleep Medicine strongly recommends pitolisant as a first-line treatment for narcolepsy, with improvements in both excessive daytime sleepiness and cataplexy 5, 2

The American Academy of Sleep Medicine conditionally recommends dextroamphetamine as a second-line treatment for narcolepsy, due to very low quality evidence, despite demonstrating clinically significant improvements in both excessive daytime sleepiness and cataplexy 1, 6, 2
The American Academy of Sleep Medicine conditionally recommends armodafinil as a second-line treatment for narcolepsy, with moderate-quality evidence 1, 4

The American Academy of Sleep Medicine recommends combining long-acting formulation (Dexedrine Spansule) with immediate-release preparation for flexible dosing 6

The American Academy of Sleep Medicine notes that dextroamphetamine is a FDA Schedule II controlled substance with a high potential for abuse and prolonged administration may lead to dependence 1, 6, 7
The American College of Obstetricians and Gynecologists notes that therapeutic use of dextroamphetamine during pregnancy does not appear associated with major congenital malformations, but it is not recommended during pregnancy or breastfeeding per American Academy of Sleep Medicine 7, 2

The American Academy of Sleep Medicine recommends monitoring for signs of tolerance requiring dose adjustments, watching for appetite suppression and weight loss, and screening for abuse or dependency behaviors 6
The American Academy of Sleep Medicine recommends assessing treatment efficacy at each visit and monitoring for signs of tolerance requiring dose adjustments 6